Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SENolytics to Improve Osteoporosis Therapy: a Randomised Controlled Clinical Trial The SENIOR Trial

NCT06018467 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT06018467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06018467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SENolytics to Improve Osteoporosis Therapy: a Randomised Controlled Clinical Trial The SENIOR Trial
Lead sponsor
Odense University Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
September 6, 2023
Completion date
April 30, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related bone loss, osteopenia, osteoporosis